Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Q32 Bio (QTTB) EBIT Margin (2018 - 2023)

Historic EBIT Margin for Q32 Bio (QTTB) over the last 6 years, with Q4 2023 value amounting to 1897.72%.

  • Q32 Bio's EBIT Margin rose 61987200.0% to 1897.72% in Q4 2023 from the same period last year, while for Sep 2024 it was 5690.07%, marking a year-over-year increase of 63361600.0%. This contributed to the annual value of 725.53% for FY2023, which is 34291100.0% up from last year.
  • Per Q32 Bio's latest filing, its EBIT Margin stood at 1897.72% for Q4 2023, which was up 61987200.0% from 419.47% recorded in Q3 2023.
  • Q32 Bio's EBIT Margin's 5-year high stood at 1897.72% during Q4 2023, with a 5-year trough of 9304.81% in Q1 2019.
  • Moreover, its 5-year median value for EBIT Margin was 4145.07% (2021), whereas its average is 3582.2%.
  • As far as peak fluctuations go, Q32 Bio's EBIT Margin tumbled by -83574300bps in 2019, and later skyrocketed by 62023300bps in 2021.
  • Quarter analysis of 5 years shows Q32 Bio's EBIT Margin stood at 4539.79% in 2019, then soared by 33bps to 3041.02% in 2020, then crashed by -38bps to 4192.64% in 2021, then decreased by -3bps to 4301.0% in 2022, then skyrocketed by 144bps to 1897.72% in 2023.
  • Its EBIT Margin was 1897.72% in Q4 2023, compared to 419.47% in Q3 2023 and 226.99% in Q2 2023.